Abstract
Previously we reported that fusogenic liposomes, prepared by fusing simple liposomes with Sendai virus particles, could introduce their contents directly and efficiently into the cytoplasm. In this study, we examined the anti-tumour activity of fusogenic liposomes containing fragment A of diphtheria toxin (DTA). Fusogenic liposomes containing DTA showed high cytotoxicity against sarcoma-180 (S-180) cells in vitro. When these liposomes were administered into the abdominal cavity of ddY mice carrying S-180, tumour cells completely disappeared in four of six tumour-bearing mice without decrease in body weight. Neither simple liposomes containing DTA nor empty fusogenic liposomes had any effect on tumour suppression. We conclude that fusogenic liposomes containing DTA are new and potentially effective tools for the treatment of ascites tumours without any severe side-effects.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mizuguchi, H., Nakanishi, M., Nakanishi, T. et al. Application of fusogenic liposomes containing fragment A of diphtheria toxin to cancer therapy. Br J Cancer 73, 472–476 (1996). https://doi.org/10.1038/bjc.1996.83
Issue Date:
DOI: https://doi.org/10.1038/bjc.1996.83
This article is cited by
-
Targeting the Inside of Cells with Biologicals: Chemicals as a Delivery Strategy
BioDrugs (2021)
-
Nanoparticle Delivery Systems in Cancer Vaccines
Pharmaceutical Research (2011)
-
Regulation of noncoding region for expression of Sendai virus hemagglutinin-neuraminidase (HN) gene
Science in China Series C: Life Sciences (1999)